Transcatheter Aortic Valve Implantation With the Edwards SAPIEN Versus the Medtronic CoreValve Revalving System Devices: A Multicenter Collaborative Study: The PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration)

Conclusions: No differences between the 2 commercially available transfemoral transcatheter aortic valve implantation devices were observed at the adjusted analysis in Valve Academic Research Consortium outcomes except for the need for permanent pacemakers with the MCV.

http://www.jaccjournaloftheacc.com/article/PIIS0735109712058603/abstract?rss=yes

Source: Journal of the American College of Cardiology - January 21, 2013 Category: Cardiology Authors: Alaide Chieffo, Gill Louise Buchanan, Nicolas M. Van Mieghem, Didier Tchetche, Nicolas Dumonteil, Azeem Latib, Robert M.A. van der Boon, Olivier Vahdat, Bertrand Marcheix, Bruno Farah, Patrick W. Serruys, Jean Fajadet, Didier Carrié, Peter P.T. de Jaeger Tags: Heart Valve Disease Source Type: research